Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Reversal of fetal ductal constriction after maternal restriction of polyphenol-rich foods: an open clinical trial

Journal of Perinatology volume 32, pages 574–579 (2012)Cite this article

Subjects

Abstract

Objective:

To test the hypothesis that maternal restriction of polyphenol-rich foods (PRF), which, like non-steroidal anti-inflammatory drugs (NSAID), inhibit prostaglandin synthesis in the third trimester, reverse fetal ductal constriction (DC).

Study Design:

An open clinical trial of 51 third trimester fetuses with DC with no history of NSAID intake was designed. All mothers were submitted to a food frequency questionnaire and were oriented to withdrawl PRF, being reassessed after 3 weeks. Doppler parameters were assessed before and after discontinuation of these substances. A control group of 26 third trimester normal fetuses, with no ductus arteriosus (DA) constriction, in which no dietary intervention was offered, was reviewed after 3 weeks. Student's t-test and Wilcoxon's test were used.

Result:

Mean gestational age was 32±3 weeks (28 to 37 weeks). After discontinuation of PRF (⩾3 weeks), 48/51 fetuses (96%) showed complete reversal of DC, with decrease in mean ductal systolic velocity (1.74±0.20 m s−1 to 1.31±0.34 m s−1, P<0.001), mean diastolic velocity (0.33±0.09 m s−1 to 0.21±0.07 m s−1, P<0.001) and mean right to left ventricular dimension ratio (1.37±0.26 to 1.12±0.17, P<0.001) and increase in mean ductal pulsatility index (PI) (1.98±0.36 to 2.46±0.23, P<0.001). Median daily maternal consumption of PRF was 286 mg per day and decreased after orientation to 0 mg per day, P<0.001. In the control group, with GA of 32±4 w (29–37 w), there was no significant differences in median daily maternal consumption of PRF, mean ductal systolic velocitiy, diastolic velocity, PI and right ventricular to left ventricular diameter ratio (RV/LV) ratio.

Conclusion:

Reduction of maternal PRF intake during pregnancy, especially in the third trimester, is followed by complete reversal of DC (wide open DA), which may influence maternal dietary habits in late pregnancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

Article 16 February 2023

Evdokia Dimitriadis, Daniel L. Rolnik, … Ellen Menkhorst

References

  1. Luchese S, Manica JL, Zielinsky P . Intrauterine ductus arteriosus constriction: analysis of a historic cohort of 20 cases. Arq Bras Cardiol 2003; 81 (4): 405–410, 399–404.

    Article  Google Scholar 

  2. Momma K, Konishi T, Hagiwara H . Characteristic morphology of the constricted fetal ductus arteriosus following maternal administration of indomethacin. Pediatr Res 1985; 19 (5): 493–500.

    Article  CAS  Google Scholar 

  3. Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME . Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 2006; 40 (5): 824–829.

    Article  CAS  Google Scholar 

  4. Toyoshima K, Takeda A, Imamura S, Nakanishi T, Momma K . Constriction of the ductus arteriosus by selective inhibition of cyclooxygenase-1 and -2 in near-term and preterm fetal rats. Prostaglandins Other Lipid Mediat 2006; 79 (1–2): 34–42.

    Article  CAS  Google Scholar 

  5. Takami T, Momma K, Imamura S . Increased constriction of the ductus arteriosus by dexamethasone, indomethacin, and rofecoxib in fetal rats. Circ J 2005; 69 (3): 354–358.

    Article  CAS  Google Scholar 

  6. Jaillard S, Elbaz F, Bresson-Just S, Riou Y, Houfflin-Debarge V, Rakza T et al. Pulmonary vasodilator effects of norepinephrine during the development of chronic pulmonary hypertension in neonatal lambs. Br J Anaesth 2004; 93 (6): 818–824.

    Article  CAS  Google Scholar 

  7. Larrue B, Jaillard S, Lorthioir M, Roubliova X, Butrous G, Rakza T et al. Pulmonary vascular effects of sildenafil on the development of chronic pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2005; 288 (6): L1193–L1200.

    Article  CAS  Google Scholar 

  8. Zenker M, Klinge J, Krüger C, Singer H, Scharf J . Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report. J Perinat Med 1998; 26 (3): 231–234.

    CAS  PubMed  Google Scholar 

  9. Talati AJ, Salim MA, Korones SB . Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report. Am J Perinatol 2000; 17 (2): 69–71.

    Article  CAS  Google Scholar 

  10. Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A et al. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 1996; 97 (5): 658–663.

    CAS  Google Scholar 

  11. Gewillig M, Brown SC, De Catte L, Debeer A, Eyskens B, Cossey V et al. Premature foetal closure of the arterial duct: clinical presentations and outcome. Eur Heart J 2009; 30 (12): 1530–1536.

    Article  Google Scholar 

  12. Trevett Jr TN, Cotton J . Idiopathic constriction of the fetal ductus arteriosus. Ultrasound Obstet Gynecol 2004; 23 (5): 517–519.

    Article  Google Scholar 

  13. Soslow JH, Friedberg MK, Silverman NH . Idiopathic premature closure of the ductus arteriosus: an indication for early delivery. Echocardiography 2008; 25 (6): 650–652.

    Article  Google Scholar 

  14. Zielinsky P, Piccoli Jr AL, Manica JL, Nicoloso LH, Frandlich R, Menezes H et al. Maternal ingestion of herbal tea and grape juice during pregnancy may cause fetal ductal constriction. Circulation 2008; 117: 54.

    Google Scholar 

  15. Zielinsky P, Piccoli Jr AL, Manica JL, Nicoloso LH, Menezes H, Busato A et al. Maternal consumption of polyphenol-rich foods in late pregnancy and fetal ductus arteriosus flow dynamics. J Perinatol 2010; 30 (1): 17–21.

    Article  CAS  Google Scholar 

  16. Zielinsky P, Piccoli Jr AL, Manica JL, Nicoloso LH . New insights on fetal ductal constriction: role of maternal ingestion of polyphenol-rich foods. Expert Rev Cardiovasc Ther 2010; 8 (2): 291–298.

    Article  CAS  Google Scholar 

  17. Sridharan S, Archer N, Manning N . Premature constriction of the fetal ductus arteriosus following the maternal consumption of camomile herbal tea. Ultrasound Obstet Gynecol 2009; 34 (3): 358–359.

    Article  CAS  Google Scholar 

  18. Kapadia V, Embers D, Wells E, Lemler M, Rosenfeld CR . Prenatal closure of the ductus arteriosus and maternal ingestion of anthocyanins. J Perinatol 2010; 30 (4): 291–294.

    Article  CAS  Google Scholar 

  19. Zielinsky P, Areias JC, Piccoli Jr AL, Manica JL, Nicoloso LH, Menezes H et al. An experimental study of the role of maternal ingestion of green tea, mate tea and grape juice as cause of fetal ductal constriction. Circulation 2008; 117: 54.

    Google Scholar 

  20. Graham HN . Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992; 21 (3): 334–350.

    Article  CAS  Google Scholar 

  21. Nag Chaudhuri AK, Karmakar S, Roy D, Pal S, Pal M, Sen T . Anti-inflammatory activity of Indian black tea (Sikkim variety). Pharmacol Res 2005; 51 (2): 169–175.

    Article  CAS  Google Scholar 

  22. Geronikaki AA, Gavalas AM . Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. Comb Chem High Throughput Screen 2006; 9 (6): 425–442.

    Article  CAS  Google Scholar 

  23. Aneja R, Odoms K, Denenberg AG, Wong HR . Theaflavin, a black tea extract, is a novel anti-inflammatory compound. Crit Care Med 2004; 32 (10): 2097–2103.

    Article  CAS  Google Scholar 

  24. Sang S, Lambert JD, Tian S, Hong J, Hou Z, Ryu JH et al. Enzymatic synthesis of tea theaflavin derivatives and their anti-inflammatory and cytotoxic activities. Bioorg Med Chem 2004; 12 (2): 459–467.

    Article  CAS  Google Scholar 

  25. Schinella GR, Troiani G, Dávila V, de uschiazzo PM, Tournier HA . Antioxidant effects of an aqueous extract of Ilex paraguariensis. Biochem Biophys Res Commun 2000; 269 (2): 357–360.

    Article  CAS  Google Scholar 

  26. Bixby M, Spieler L, Menini T, Gugliucci A . Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: a comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci 2005; 77 (3): 345–358.

    Article  CAS  Google Scholar 

  27. Actis-Goretta L, Mackenzie GG, Oteiza PI, Fraga CG . Comparative study on the antioxidant capacity of wines and other plant-derived beverages. Ann N Y Acad Sci 2002; 957: 279–283.

    Article  CAS  Google Scholar 

  28. de la Lastra CA, Villegas I . Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 2005; 49 (5): 405–430.

    Article  CAS  Google Scholar 

  29. Sun J, Chu YF, Wu X, Liu RH . Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem 2002; 50 (25): 7449–7454.

    Article  CAS  Google Scholar 

  30. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L . A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124 (3): 453–469.

    Article  CAS  Google Scholar 

  31. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122 (1): 51–65.

    Article  CAS  Google Scholar 

  32. USDA Database for the Flavonoid Content of Selected Foods. Release 2.1. Web site http://www.ars.usda.gov/nutrientdata,January 2007.

  33. Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C et al. How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 2004; 80 (1): 15–21.

    Article  CAS  Google Scholar 

  34. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C . Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81 (Suppl 1): 230S–242S.

    Article  CAS  Google Scholar 

  35. Huhta JC, Moise KJ, Fisher DJ, Sharif DS, Wasserstrum N, Martin C . Detection and quantitation of constriction of the fetal ductus arteriosus by Doppler echocardiography. Circulation 1987; 75 (2): 406–412.

    Article  CAS  Google Scholar 

  36. Mielke G, Benda N . Blood flow velocity waveforms of the fetal pulmonary artery and the ductus arteriosus: reference ranges from 13 weeks to term. Ultrasound Obstet Gynecol 2000; 15 (3): 213–218.

    Article  CAS  Google Scholar 

  37. Momma K, Takeuchi H . Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. Prostaglandins 1983; 26 (4): 631–643.

    Article  CAS  Google Scholar 

  38. Rudolph AM . The effects of nonsteroidal antiinflammatory compounds on fetal circulation and pulmonary function. Obstet Gynecol 1981; 58 (5 Suppl): 63S–67S.

    CAS  PubMed  Google Scholar 

  39. Zuckerman H, Shalev E . Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol 1985; 153 (6): 712–713.

    Article  CAS  Google Scholar 

  40. Takizawa T, Kihara T, Kamata A, Yamamoto M, Arishima K . Role of nitric oxide in regulating the ductus arteriosus caliber in fetal rats. J Vet Med Sci 2000; 62 (7): 707–710.

    Article  CAS  Google Scholar 

  41. Van Overmeire B, Chemtob S . The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 2005; 10 (2): 177–184.

    Article  Google Scholar 

  42. Respondek M, Weil SR, Huhta JC . Fetal echocardiography during indomethacin treatment. Ultrasound Obstet Gynecol 1995; 5 (2): 86–89.

    Article  CAS  Google Scholar 

  43. Broussard CS, Louik C, Honein MA, Mitchell AA . Herbal use before and during pregnancy. Am J Obstet Gynecol 2010; 202 (5): 443 e1-6.

    Article  Google Scholar 

  44. Holst L, Wright D, Haavik S, Nordeng H . The use and the user of herbal remedies during pregnancy. J Altern Complement Med 2009; 15 (7): 787–792.

    Article  Google Scholar 

  45. Louik C, Gardiner P, Kelley K, Mitchell AA . Use of herbal treatments in pregnancy. Am J Obstet Gynecol 2010; 202 (5): 439 e1–439 e10.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fetal Cardiology Unit, Instituto de Cardiologia do Rio Grande do Sul/ FUC (IC/FUC), Porto Alegre, Brazil

    P Zielinsky, A L Piccoli Jr, J L L Manica, L H Nicoloso, I Vian, L Bender, P Pizzato, M Pizzato, F Swarowsky, C Barbisan, A Mello & S C Garcia

Authors
  1. P Zielinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A L Piccoli Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J L L Manica
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L H Nicoloso
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I Vian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Bender
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P Pizzato
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Pizzato
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. F Swarowsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C Barbisan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A Mello
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. S C Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Zielinsky.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zielinsky, P., Piccoli, A., Manica, J. et al. Reversal of fetal ductal constriction after maternal restriction of polyphenol-rich foods: an open clinical trial. J Perinatol 32, 574–579 (2012). https://doi.org/10.1038/jp.2011.153

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2011.153

Keywords

This article is cited by

Search

Advanced search

Quick links